Pfizer, Ping An, Tencent, and Legend Capital Launch 'Healthcare Partners' Innovation Collaboration Initiative to Build an Integrated Medical Resource Platform

2015Year12Month22Beijing, [Date] ———In 2015, as mobile internet penetration deepened its influence, a continuous stream of new pharmaceutical policies was introduced. China’s healthcare industry also ushered in a year of vigorous development, with various new products, business models, and market entrants flooding in to actively seize opportunities for industry growth. However, addressing the industry’s pain points and accelerating its transformation proved difficult to achieve solely through the efforts of entrepreneurs and capital support. In this context, Pfizer China, Ping An Insurance, Tencent, and Legend Capital joined forces across industries to co-host the “Healthcare Partners” Innovation Collaboration Competition. This initiative warmly invited healthcare startup teams to participate, aiming to integrate resources from all parties, enhance the construction of the healthcare ecosystem, seek mutual benefits, and explore innovative healthcare models that effectively benefit Chinese patients. This marked the first cross-sector collaboration among the pharmaceutical, internet, insurance, and venture capital industries to jointly create a comprehensive healthcare resource platform.


Seeking Pragmatic Cooperation Solutions

 Unlike the mobile health startup competitions that have been held frequently in recent times, this competition focuses on “collaboration.” Currently, the healthcare service industry chain has achieved certain successes in localized innovation. However, while various segments appear interconnected, they essentially operate independently. True transformation in the healthcare sector cannot be achieved by any single party alone; rather, it requires collaborative efforts that leverage the strengths of all stakeholders. Therefore, this competition aims to identify the most practical project proposals that can effectively link various segments of the emerging healthcare industry chain, facilitate actionable business integration, explore innovative business models, and ultimately enhance the efficiency and quality of healthcare services, thereby truly benefiting patients at large. The competition will extensively invite teams from diverse fields within the healthcare and medical industries to participate. Moreover, it encourages not only early-stage startups to register but also welcomes mature, well-established projects to join in shaping strategic initiatives.


Build a Premier Resource Support Platform

 Pfizer is a leading enterprise in the pharmaceutical industry, while Ping An, Tencent, and Legend Capital have long established their presence in the healthcare sector. For the first time, these four organizers have come together across industry boundaries to engage with outstanding teams and jointly explore innovative resource integration and ecosystem models. Outstanding participating teams will be invited to closed-door in-depth discussions, with the prospect of accessing the advantageous resources provided by the four organizers and ultimately achieving project collaboration. Pfizer will leverage its extensive medical resources to offer deep cooperation opportunities in therapeutic areas such as cardiovascular diseases, central nervous system disorders, oncology, and smoking cessation. China Ping An will provide its abundant resources in commercial insurance, social health insurance, and financial institutions, along with collaborative support for its portfolio healthcare companies. Tencent will offer resources including precise traffic support, financing opportunities, resource matchmaking, and incubation support, such as 3–6 months of free office space. In addition to direct financial investment, Legend Capital will provide entrepreneurship training and angel investment from Legend Star, incubator services from Suzhou Kailian, and synergistic resources from companies previously invested in by Legend Star and Legend Capital in the fields of medical devices, pharmaceuticals, and healthcare services.

 Meanwhile, the organizers of the “Medical Partner” Innovative Collaboration Proposal Competition will also invite stakeholders from venture capital, media, incubation, and professional societies to become conference partners, jointly focusing on innovation in healthcare models. The competition officially launched its project recruitment on December 22. In late February, outstanding teams will engage in a series of in-depth offline discussions with the organizers. In March, the first round of selected top teams will present their pitches. Teams participating in the pitch sessions will compete for awards including the “Best Business Model Award,” “Most Collaborative Value Award,” “Most Innovative Spirit Award,” and “Best Communication Grand Prize.”

Registration for the competition has officially opened. The deadline for submitting project proposals is February 13, 2016. For more details, please visit the official registration platform.http://www.cyzone.cn/features/hcpartners/。

About Pfizer

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. In the discovery, development, and manufacture of medicines, we are committed to setting standards for quality, safety, and value. Our diverse portfolio of global healthcare products includes biologics, small-molecule drugs, and vaccines, as well as many world-renowned consumer health products. Every day, Pfizer colleagues in both mature and emerging markets around the world work to advance health and develop preventive and therapeutic solutions capable of addressing some of the most challenging diseases of our time. We also collaborate with healthcare professionals, governments, and local communities to support greater access to reliable and affordable healthcare for people worldwide, consistent with our responsibilities as a leading global biopharmaceutical company. For more than 160 years, Pfizer has worked tirelessly to better serve all those who rely on us.



For more information about Pfizer China, please visithttp://www.pfizer.com.cn, or scan the QR code to follow Pfizer China’s official Weibo and WeChat accounts.


About Tencent

Tencent enriches the lives of internet users through technology. Every day, hundreds of millions of users communicate online, share experiences, access information, and seek entertainment through our integrated platform. Tencent’s diversified services include: social networking and communication services QQ and WeChat; the social networking platform Qzone; the QQ Games platform under Tencent Games; the portal website Tencent.com (QQ.com); the Tencent News client; and the online video service Tencent Video. Founded in Shenzhen, China, in 1998, Tencent was listed on the Main Board of The Stock Exchange of Hong Kong in 2004. Tencent is a constituent stock of the Hang Seng Index. By investing in innovation, fostering a favorable environment for partners, and staying close to user needs, Tencent is committed to growing together with the internet.


About Ping An of China

As China’s first joint-stock insurance enterprise, Ping An Insurance (Group) Company of China, Ltd. (“Ping An”) is committed to becoming an internationally leading provider of personal financial and lifestyle services. It has evolved into a comprehensive financial services group integrating insurance, banking, investment, and other businesses. Ping An is the personal financial and lifestyle services group in China with the most complete set of financial licenses, the broadest business scope, and the most tightly integrated holding structure. Its subsidiaries include Ping An Life Insurance, Ping An Property & Casualty Insurance, Ping An Pension Insurance, Ping An Health Insurance, Ping An Bank, Ping An Securities, Ping An Trust, and Ping An DaHua Fund, among others. Covering all sectors of the financial industry, Ping An has become one of the few financial institutions in China capable of providing customers with comprehensive financial products and services across insurance, banking, and investment. In addition, Ping An has actively expanded its internet finance businesses, including Lufax, Wanlitong, Ping An Good Car, Ping An Good Home, and Ping An Pay, achieving significant growth in both scale and user base. As of the end of September 2015, Ping An’s internet user base reached 197 million.

Ping An of China ranked 32nd in the latest edition of Forbes’ “Global 2000” list; it placed 96th in Fortune’s “Global 500,” retaining its position as the top non-state-owned enterprise from mainland China. Additionally, it ranked 77th in the “Top 100 Global Brands” list published by Millward Brown, a subsidiary of the UK-based WPP Group.

About Legend Capital

In 2001, Liu Chuanzhi, President of Legend Holdings, assembled a team led by Zhu Linan to enter the investment sector, committing USD 35 million from Legend Holdings as the first fund. Thus, Legend Capital was established in April 2001. Legend Capital operated as an independent professional venture capital firm under Legend Holdings. In February 2012, Legend Capital was renamed Legend Capital (now known as Junlian Capital).

Legend Capital’s core business is positioned in venture capital for startups and growth investment for expansion-stage companies.

As of September 2015, Legend Capital had invested in more than 260 portfolio companies. Among them, over 30 were listed on the New York Stock Exchange (NYSE), NASDAQ, Hong Kong Stock Exchange, Taipei Exchange (TPEx), Shanghai Stock Exchange, and the SME Board and ChiNext of the Shenzhen Stock Exchange, while an additional 20 companies achieved exit through mergers and acquisitions.

Legend Capital began its strategic investments in the healthcare sector in 2008, covering multiple sub-sectors including healthcare services, biopharmaceuticals, medical devices, and diagnostics. Over the past seven years, it has invested in 40 healthcare-related projects, with a total investment volume exceeding USD 300 million. Among these, four projects have achieved exit through IPOs or mergers and acquisitions, while the majority of portfolio companies have demonstrated steady growth in operational performance and significant appreciation in market value post-investment.

Legend Capital envisions becoming “the most valuable, most respected, and internationally influential investment firm.” By providing capital and managerial support, it fosters corporate innovation and growth, plays a positive role in advancing industry progress and social development, and strives to co-create fulfilling ventures with like-minded partners while sharing success.